|
|
Volumn 151, Issue 1, 2011, Pages 183-
|
|
Clinical trial of 0.02% polyhexamethylene biguanide versus placebo in the treatment of microsporidial keratoconjunctivitis
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALBENDAZOLE;
CHLORAMPHENICOL;
GATIFLOXACIN;
PLACEBO;
POLY(HEXAMETHYLENEBIGUANIDE);
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
ADD ON THERAPY;
ANTIBIOTIC THERAPY;
COMBINATION CHEMOTHERAPY;
DISEASE ASSOCIATION;
DRUG EFFICACY;
DRUG SUBSTITUTION;
FOLLOW UP;
HUMAN;
LETTER;
MICROSPORIDIOSIS;
MONOTHERAPY;
PRIORITY JOURNAL;
TREATMENT RESPONSE;
UVEITIS;
ADMINISTRATION, TOPICAL;
BIGUANIDES;
DISINFECTANTS;
DOUBLE-BLIND METHOD;
EYE INFECTIONS, FUNGAL;
HUMANS;
KERATOCONJUNCTIVITIS;
MICROSPORIDA;
MICROSPORIDIOSIS;
OPHTHALMIC SOLUTIONS;
TREATMENT OUTCOME;
VISUAL ACUITY;
|
|
EID: 78650426734
PISSN: 00029394
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ajo.2010.08.029 Document Type: Letter |
|
Times cited : (3)
|
|
References (3)
|
